Solara Active Pharma Sciences Ltd Board of Directors
Board of Directors at Solara Active Pharma Sciences Ltd
Non Executive Director
Non Executive Director
Independent Director
Executive Director & COO
Non Executive Director
Key Highlights
- Ramakrishnan Rajagopal joins the board as Chairman & Independent Directo, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Kausalya Santhanam joins the board as Independent Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Rajendra Kumar Srivastava joins the board as Independent Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Rajiv Vijay Nabar joins the board as Independent Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Arun Kumar Pillai joins the board as Non Executive Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Solara Active Pharma Sciences Ltd
NSE: SOLARA
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 23 Oct 2026 | 612.2 |
| 22 Oct 2026 | 618.65 |
| 21 Oct 2026 | 648.1 |
| 19 Oct 2026 | 647.45 |
| 16 Oct 2026 | 696.3 |
| 15 Oct 2026 | 652.8 |
| 14 Oct 2026 | 640.5 |
| 13 Oct 2026 | 656.7 |
| 12 Oct 2026 | 662.2 |
| 09 Oct 2026 | 645.3 |
Company Fundamentals for Solara Active Pharma Sciences Ltd
Market Cap
2,971 Cr
EPS
9.8
P/E Ratio (TTM)
62.8
P/B Ratio (TTM)
2.1
Day’s High
631.0
Day’s Low
592.0
DTE
0.4
ROE
3.3
52 Week High
774.0
52 Week Low
422.85
ROCE
6.7
Market Price of Solara Active Pharma Sciences Ltd
1M
1Y
3Y
5Y
Solara Active Pharma Sciences Ltd News Hub
Solara Active Pharma Sciences schedules AGM
Solara Active Pharma Sciences announced that the Annual General Meeting (AGM) of the company will be
Read more
30 Aug 24
Solara Active Pharma Sciences to incorporate wholly owned subsidiary
Solara Active Pharma Sciences approved the incorporation of wholly owned subsidiary in relation to p
Read more
07 Feb 25
Solara Active Pharma Sciences reports consolidated net profit of Rs 8.01 crore in the September 2024 quarter
Net profit of Solara Active Pharma Sciences reported to Rs 8.01 crore in the quarter ended September
Read more
21 Oct 24
Solara Active Pharma Sciences allots 49,000 equity shares under ESOP
Solara Active Pharma Sciences has allotted 49,000 equity shares under ESOP on 21 October 2024. Power
Read more
21 Oct 24
